Abstract
To minimize patient exposure to COVID-19 and limit healthcare utilization during the pandemic, the Society of Obstetricians and Gynaecologists of Canada and Diabetes Canada recommended a temporary alternative screening strategy for Gestational Diabetes Mellitus (GDM). Rather than the standard two-step approach using glucose challenge and oral glucose tolerance tests, the alternative strategy used a hemoglobin A1c and a random plasma glucose. The primary objective was to compare GDM diagnosis using the alternative screening strategy to the two-step approach, and secondarily to compare pharmacotherapy needs and perinatal outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
